Palomino Laboratories (PALX) Change in Account Payables (2023 - 2025)

Palomino Laboratories has disclosed Change in Account Payables across 3 years of filings, most recently posting $51161.0 for Q3 2025.

• Change in Account Payables for Q3 2025 came in at $51161.0, up 699.43% year-over-year; the trailing twelve-month figure through Sep 2025 was $25696.0 (up 509.63% YoY), and the FY2024 annual result was -$32000.0, down 288.24% from the prior year.
• Change in Account Payables came in at $51161.0 for Q3 2025 at Palomino Laboratories, up from $1114.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $51161.0 in Q3 2025 to a low of -$31965.0 in Q4 2024.
• The 3-year median for Change in Account Payables is $4250.0 (2023), against an average of $3878.3.
• Across the five-year window, Change in Account Payables tumbled 852.12% in 2024 and soared 699.43% in 2025, its largest moves.
• Palomino Laboratories' Change in Account Payables stood at $4250.0 in 2023, then sank by 852.12% to -$31965.0 in 2024, then jumped by 260.05% to $51161.0 in 2025.
• The last three Change in Account Payables figures came in at $51161.0 (Q3 2025), $1114.0 (Q2 2025), and $5386.0 (Q1 2025), per Business Quant data.